SCHEMBL30762426

SCHEMBL30762426

CC(=O)c1cc(Cl)cc2c(C#C[Si](C)(C)C)cc(N3CCOCC3)nc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ ATR Q13535 2/20 0.39
▸ PKM P14618 1/20 0.38
▸ PIK3C2B O00750 1/20 0.36
▸ KDM4E B2RXH2 4/20 0.36
▸ HIF1A Q16665 2/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ HTT P42858 2/20 0.36
▸ THRB P10828 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30762537 0.87 HTT (0.49) KMT2AMEN1NPC1RAB9ANPSR1
SCHEMBL30762539 0.79 KMT2A (0.40) KMT2AMEN1NPC1RAB9AATR
SCHEMBL30762469 0.76 ALDH1A1 (0.50) KMT2AMEN1NPSR1KDM4EALDH1A1
SCHEMBL30762505 0.75 L3MBTL1 (0.50) KMT2AMEN1ATRPKMPIK3C2B
SCHEMBL30808225 0.73 MET (0.47) KMT2AMEN1NPC1RAB9ANPSR1
SCHEMBL30762601 0.72 HTT (0.47) ATRKDM4EALDH1A1HTTLMNA
SCHEMBL30783687 0.72 NPSR1 (0.44) KMT2AMEN1NPSR1ALDH1A1HPGD
SCHEMBL30784011 0.72 NPSR1 (0.42) KMT2AMEN1NPC1RAB9ANPSR1
SCHEMBL30762629 0.71 ALDH1A1 (0.45) KMT2AMEN1NPSR1KDM4EALDH1A1
SCHEMBL24312182 0.71 KMT2A (0.46) KMT2AMEN1NPC1RAB9ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026423-A1 SUBSTITUTED QUINOLINE DERIVATIVES AS PI3K INHIBITORS BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback